Kiranmai Gumireddy

The Wistar Institute, USA 
"Kiranmai Gumireddy"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Perales-Puchalt A, Svoronos N, Rutkowski MR, et al. (2016) FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Gumireddy K, Li A, Kossenkov AV, et al. (2016) The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nature Communications. 7: 10715
Gumireddy K, Yan J, Huang Q. (2016) Isolation of Protein Complexes Associated with Long Noncoding RNAs. Methods in Molecular Biology (Clifton, N.J.). 1402: 27-32
Gumireddy K, Li A, Chang DH, et al. (2015) AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget
Chen K, Yu G, Gumireddy K, et al. (2015) ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer. Oncotarget. 6: 6959-76
Yu G, Yao W, Gumireddy K, et al. (2014) Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Molecular Cancer Therapeutics. 13: 3086-97
Gumireddy K, Li A, Kossenkov AV, et al. (2014) ID1 promotes breast cancer metastasis by S100A9 regulation. Molecular Cancer Research : McR. 12: 1334-43
Yu G, Li H, Wang J, et al. (2014) miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. The Journal of Urology. 192: 1229-37
Gumireddy K, Li A, Cao L, et al. (2013) NOV-002, A Glutathione Disulfide Mimetic, Suppresses Tumor Cell Invasion and Metastasis. Journal of Carcinogenesis & Mutagenesis. 2013
Yan J, Gumireddy K, Li A, et al. (2013) Regulation of mesenchymal phenotype by MicroRNAs in cancer. Current Cancer Drug Targets. 13: 930-4
See more...